The purpose of this research study is to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb and evaluate the effects of treatment on long-term neurodevelopmental outcome at 18 months of age. The goal is to compare the two most commonly used drugs and see which requires fewer days in the hospital to complete treatment. The study will also determine if genetic variations contribute to the severity of NAS.
This research study is led by Dr. Rachana Singh.
Contact: Rachana Singh, MD, 413-794-5370
Baystate Children's Hospital, 759 Chestnut Street, Springfield, MA 01199